Javier Rodriguez, See Remarks at BioXcel Therapeutics, Inc. (BTAI), sold 361 shares at $1.26 ($455) on 2024-06-17, disclosed to the SEC on 2024-06-18.
Scheduled sale ($455) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| BTAI | SELL | 2024-10-03 | $4K | — | Filing → |
| DVA | SELL | 2024-09-17 | $19.7M | — | Filing → |
| BTAI | SELL | 2024-09-17 | $238 | — | Filing → |